Teams of AI agents boost speed of research

2026-05-19 · Source: Machine learning : nature.com subject feeds · Field: Science & Research — Life Sciences & Biology, Health & Medical Research, Research Methodology & Innovation · Depth: Expert, quick

Summary

Two new AI systems, Google's Co-Scientist and FutureHouse's Robin, described in *Nature*, use teams of AI agents to accelerate scientific research. These systems develop hypotheses, propose experiments, and analyze data, significantly shortening timelines compared to human-only processes. Co-Scientist identified candidate drugs for acute myeloid leukaemia, with three showing promise in preliminary lab studies. Robin, designed for dry age-related macular degeneration, used AI agents for literature reviews and data analysis, suggesting ripasudil (a glaucoma drug) as a candidate treatment and proposing follow-up experiments. While human input is still required, these AI co-scientists can generate plausible hypotheses in hours, aiming to augment human researchers. The identified drugs require full evaluation, as initial lab assay success does not guarantee broader efficacy.

Key takeaway

For Research Scientists and Directors of AI/ML evaluating new drug discovery platforms, these AI co-scientist systems offer a significant acceleration in hypothesis generation and candidate identification. You should consider integrating AI agent teams to rapidly screen drug repurposing candidates or explore novel molecular targets. Be aware that while initial results are promising, full validation of AI-identified candidates still requires rigorous human-led experimental evaluation.

Key insights

AI agent teams can rapidly generate plausible scientific hypotheses and identify drug candidates, significantly accelerating early-stage research.

Principles

• AI agents can simulate scientific thought processes.
• Human-AI collaboration enhances research speed.
• Iterative AI-driven hypothesis generation is effective.

Method

Systems like Robin use specialized AI agents for literature review, experiment selection, and data analysis, with human execution of experiments and data feedback loops.

In practice

• Apply AI agents for drug repurposing screening.
• Integrate AI for literature review and hypothesis generation.
• Use AI for initial data analysis in drug discovery.

Topics

• AI Agents
• Drug Discovery
• Hypothesis Generation
• Scientific Research Automation
• Acute Myeloid Leukaemia
• Macular Degeneration

Best for: AI Scientist, Research Scientist, Director of AI/ML

Related on AIssential

• Two AI-based science assistants succeed with drug-retargeting tasks — AI-powered agentic systems can accelerate scientific discovery by synthesizing vast literature and generating testable hypotheses.
• Accelerating discovery of liver disease mechanisms — AI-driven literature analysis can uncover novel biological hypotheses and candidate therapies for complex diseases.
• Using AI to Develop New Drugs — AI is fundamentally transforming drug discovery and development processes.
• He Raised $70M to Cure Every Disease With AI — AI agents, particularly specialized models, significantly accelerate scientific discovery by removing human talent bottlenecks and enabling high-throughput reasoning.
• Demis Hassabis On What AI Will Do Next — AI is evolving into a co-creative partner, poised to accelerate scientific discovery and revolutionize human health within decades.
• 3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs — AI, particularly deep learning and generative models, significantly accelerates novel antibiotic discovery and design.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.